AstraZeneca PLC (AZN) NYSE
204.38
+2.14(+1.06%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
204.38
+2.14(+1.06%)
Currency In USD
| Market Cap | 136.01B |
| Enterprise Value | 160B |
| P/E Ratio | 30.57 |
| PEG Ratio | 3.34 |
| Price/Sales Ratio | 5.33 |
| Price/Book Ratio | 6.51 |
| Enterprise/Revenue | 5.73 |
| Enterprise/EBITDA | 17 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.17 |
| Operating Margin | 0.23 |
| Return On Assets | 0.09 |
| Return On Equity | 0.23 |
| Revenue | 58.74B |
| Revenue/Share | 38.36 |
| Gross Profit | 48.11B |
| EBITDA | 19.83B |
| Net Income | 10.26B |
| Diluted EPS | 13.08 |
| Total Cash | 5.74B |
| Total Cash/Share | 3.7 |
| Total Debt | 29.7B |
| Total Debt/Equity | 0.61 |
| Current Ratio | 0.94 |
| Book Value Per Share | 31.41 |
| 52-Week Change | 52.27 |
| 52-Week High | 212.71 |
| 52-Week Low | 132.32 |
| Moving Average 50 Days | 197.07 |
| Moving Average 200 Days | 173.9 |
| Average Volume | 2.8M |
| Shares Outstanding | 1.55B |
| % Held by Institutions | 15.66 |
| Trailing Annual Dividend Rate | 3.2 |
| Trailing Annual Dividend Yield | 1.57 |
| Payout Ratio | 0.48 |
| Last Split Factor | 1:2 |
| Last Split Date | February 02, 2026 |